Ionis Pharmaceuticals (IONS) Other financing activities (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Other financing activities of $20.3 million for Q2 2026, up 1474.05% year-over-year from $1.3 million in Q2 2025, and down 64.65% quarter-over-quarter from $57.3 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Other financing activities (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Other financing activities history runs 18 years deep, the most recent figure standing at $20.3 million for Q2 2026.
- In Q2 2026, Other financing activities rose 1474.05% year-over-year to $20.3 million; the TTM figure through Jun 2026 stood at $266.6 million (up 2339.04% YoY), while the FY2025 annual figure was $192.6 million, up 473.07% from the prior year.
- Other financing activities for Q2 2026 stood at $20.3 million, down from $57.3 million in the prior quarter.
- The five-year high for Other financing activities was $500.0 million in Q1 2023, with the low at $343000.0 in Q4 2022.
- The 5-year median for Other financing activities is $2.6 million (2024), against an average of $54.0 million.
- The sharpest annual moves came in 2023 and 2024: Other financing activities soared 26956.28% in 2023, then slumped 95.28% in 2024.
- Ionis Pharmaceuticals' Other financing activities stood at $343000.0 in 2022, then jumped by 145672.59% to $500.0 million in 2023, then slumped by 99.92% to $402000.0 in 2024, then soared by 26720.15% to $107.8 million in 2025, then plunged by 81.21% to $20.3 million in 2026.
- Business Quant data shows IONS's Other financing activities at $20.3 million in Q2 2026, $57.3 million in Q1 2026, and $107.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.26 Mn |
| Jun 30, 2026 | 20.26 Mn |
| Mar 31, 2026 | 57.30 Mn |
| Mar 31, 2026 | 57.30 Mn |
| Dec 31, 2025 | 107.82 Mn |
| Dec 31, 2025 | 107.82 Mn |
| Sep 30, 2025 | 81.26 Mn |
| Sep 30, 2025 | 81.26 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | 402,000.00 |
| Dec 31, 2024 | 402,000.00 |
| Sep 30, 2024 | 7.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | 23.61 Mn |
| Mar 31, 2024 | 23.61 Mn |